| 書(shū)目名稱 | Combination Cancer Therapy |
| 副標(biāo)題 | Modulators and Poten |
| 編輯 | Gary K. Schwartz |
| 視頻video | http://file.papertrans.cn/230/229856/229856.mp4 |
| 概述 | Includes supplementary material: |
| 叢書(shū)名稱 | Cancer Drug Discovery and Development |
| 圖書(shū)封面 |  |
| 描述 | Expert physician-scientists and clinicians review those combinations of novel target agents classic chemotherapies that hold the most promise for the future of medical oncology, and detail their optimal sequence, pharmacokinetic interactions, and interaction with downstream cellular signals. The combinations run the gamut of targeted therapies against cell surface receptors (EGF-R and HER2), the cell cycle (the CDKs), signal transduction events (PKC and NF-kB), apoptosis (bcl-2), as well as focused therapies in ovarian cancer, hematologic diseases, and breast cancer. The authors emphasize novel translational approaches that are rapidly moving from the laboratory bench top to the patient‘s bedside for the future treatments in cancer therapy. |
| 出版日期 | Book 2005 |
| 關(guān)鍵詞 | Chemotherapie; apoptosis; carcinoma; cell; leukemia; ovarian cancer |
| 版次 | 1 |
| doi | https://doi.org/10.1385/1592598641 |
| isbn_softcover | 978-1-62703-806-5 |
| isbn_ebook | 978-1-59259-864-9Series ISSN 2196-9906 Series E-ISSN 2196-9914 |
| issn_series | 2196-9906 |
| copyright | Humana Press 2005 |
|Archiver|手機(jī)版|小黑屋|
派博傳思國(guó)際
( 京公網(wǎng)安備110108008328)
GMT+8, 2026-1-31 03:32
發(fā)表于 2025-3-21 17:41:59
